Equitable Holdings’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.4K | Buy |
17,060
+5,000
| +41% | +$11K | ﹤0.01% | 1442 |
|
|
2025
Q1 | $13K | Hold |
12,060
| – | – | ﹤0.01% | 1333 |
|
|
2024
Q4 | $12.5K | Hold |
12,060
| – | – | ﹤0.01% | 1261 |
|
|
2024
Q3 | $15.1K | Sell |
12,060
-197,940
| -94% | -$247K | ﹤0.01% | 1255 |
|
|
2024
Q2 | $250K | Buy |
210,000
+10,000
| +5% | +$11.9K | ﹤0.01% | 1049 |
|
|
2024
Q1 | $202K | Buy |
200,000
+35,000
| +21% | +$35.4K | ﹤0.01% | 1093 |
|
|
2023
Q4 | $175K | Buy |
165,000
+30,000
| +22% | +$31.8K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $221K | Hold |
135,000
| – | – | ﹤0.01% | 971 |
|
|
2023
Q2 | $212K | Buy |
135,000
+5,000
| +4% | +$7.85K | ﹤0.01% | 969 |
|
|
2023
Q1 | $186K | Buy |
130,000
+17,000
| +15% | +$24.3K | ﹤0.01% | 933 |
|
|
2022
Q4 | $267K | Buy |
113,000
+3,000
| +3% | +$7.08K | ﹤0.01% | 768 |
|
|
2022
Q3 | $222K | Hold |
110,000
| – | – | ﹤0.01% | 774 |
|
|
2022
Q2 | $245K | Buy |
110,000
+6,000
| +6% | +$13.4K | ﹤0.01% | 755 |
|
|
2022
Q1 | $695K | Buy |
104,000
+2,000
| +2% | +$13.4K | 0.01% | 500 |
|
|
2021
Q4 | $564K | Buy |
102,000
+2,000
| +2% | +$11.1K | 0.01% | 541 |
|
|
2021
Q3 | $916K | Buy |
100,000
+5,700
| +6% | +$52.2K | 0.02% | 403 |
|
|
2021
Q2 | $1.05M | Hold |
94,300
| – | – | 0.02% | 360 |
|
|
2021
Q1 | $805K | Hold |
94,300
| – | – | 0.02% | 399 |
|
|
2020
Q4 | $548K | Buy |
94,300
+34,000
| +56% | +$198K | 0.01% | 439 |
|
|
2020
Q3 | $160K | Buy |
+60,300
| New | +$160K | ﹤0.01% | 602 |
|